Shared genetic marker offers new promise in targeting specific ovarian and lung cancers
Two new papers offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer
A hide-out for viruses in the testicles
RI-MUHC team leads an innovative study using testicular tissue to unlock the secrets of the immune system...
Quebec researchers among recipients of $34 million “Grand Challenge” Grant from Cancer Research UK to combat cancer
Research teams from McGill and MUHC are part of an international effort to uncover how chronic inflammation causes cancer
Confronting a killer
Defeating tuberculosis (TB) will require in-depth collaboration, including researchers, medical professionals but also the communities...
Global resource helps to inform understanding of cancer risk
McGill University has helped develop a global resource that includes data on thousands of inherited variants in the BRCA1 and...
Québec Science magazine honours a team from the RI-MUHC!
Recent work by McGill University Health Centre (MUHC) gyneco-oncologists, Drs. Lucy Gilbert, Xing Zeng and Kris Jardon, along with...
Suboptimal, inconsistent treatment for anaphylaxis due to unknown cause
A new Canadian study, led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC), is shedding light on...
Wound care revolution: Put away your rulers and reach for your phone
Monitoring a wound is critical, especially in diabetic patients, whose lack of sensation due to nerve damage can lead to infection of a lesion...
Innovative biosensor technology reveals secrets of how drugs work
What if we could take advantage of a drug’s benefit without side effects? Stéphane Laporte, PhD is conducting research in his laboratory at the Glen...
How does cancer spread?
How does cancer spread? While studying human brain tumour cells, a team of scientists at the Research Institute of the McGill University...